External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

WFH 2024

April 21 - April 24

Madrid, Spain

wfh.org

Add to calendar

Medical Materials

Agenda

Coming soon

07:00 AM

Duration 1hr Madrid, Spain

Effectiveness of starting emicizumab in routine clinical practice for patients with severe hemophilia A without FVIII inhibitor: results using PicnicHealth data in the United States

Pipe SW, Sharma N, Siadimas A, Liao N, Hanson G, Chafaie R, Moreno K, Biondo J, Polito L

Haematology | Hemophilia A

Add to calendar

Duration 15mins Madrid, Spain

Exploring Baseline Characteristics, Treatment Decisions and Patient-centred Outcomes of People with Severe Haemophilia A Receiving Prophylaxis: Early Findings from the Multi-country ‘Cost of Haemophilia: a Socioeconomic Survey III’ (CHESS III) Study

Chowdary P, Polito L, Chafaie R, Moreno K, Blenkiron T, Burke T, Ferri Grazzi E

Haematology | Hemophilia A

Add to calendar

Duration 15mins Madrid, Spain

Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Primary Analysis of the HAVEN 7 Study

Pipe S, Collins P, Dhalluin C, Kenet G, Schmitt C, Buri M, Jiménez-Yuste V, Peyvandi F, Young G, Oldenburg J, Mancuso ME, Kavakli K, Kiialainen A, Chang T, Lehle M, Niggli M, Fijnvandraat K

Haematology | Hemophilia A

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.